From: Effects of Chinese medicine for COVID-19 rehabilitation: a multicenter observational study
(A) Baseline characteristics of participants | |||
---|---|---|---|
 | Participants with particular CM syndromes | Participants without particular CM syndromes | P-value |
No. of participants, N (% of total) | 107 (71.3%) | 43 (28.7%) | Â |
Female, N (% of group) | 68 (63%) | 28 (66%) | 1.000 |
Age, years | 54 (43–61.5) | 54 (38–60.5) | 0.269 |
Height, cm | 162.5 (158–167.2) | 160 (156.8–170) | 0.591 |
Weight, kg | 63.75 (55–71.4) | 70 (60.23–78.25) | 0.040 |
No. of participants requiring mechanical ventilation during hospitalization, N (% of total) | 11 (10.19%) | 3 (7.14%) | 0.750 |
Hospitalization Days, days | 16 (12–18.34) | 17 (12–27.5) | 0.185 |
BMI score | 23.2 (21.15–23.93) | 24.8 (23.05–28.93) | 0.005 |
No. of participants with medical history, N (% of total) | 69 (63.89%) | 22 (52.38%) | 0.185 |
No. of smokers, N (% of total) | 18 (16.67%) | 6 (14.29%) | 0.852 |
(B) Changes in the number (and percentage) of participants with the two particular CM syndromes in COVID-19 rehabilitation | |||||||||
---|---|---|---|---|---|---|---|---|---|
Participants exhibiting: | Qi Deficiency of Lung and Spleen only | Qi and Yin Deficiency only | Both CM Syndromes | Without CM Syndromes | Total N | ||||
 | N | % | N | % | N | % | N | % |  |
V1 | 27 | 18 | 15 | 10 | 65 | 43.4 | 43 | 28.67 | 150 |
V2 | 22 | 14.77 | 14 | 9.4 | 63 | 42.28 | 50 | 33.56 | 149 |
V3 | 22 | 15.17 | 7 | 4.83 | 57 | 39.31 | 59 | 40.69 | 145 |
V4 | 21 | 14.58 | 14 | 9.72 | 51 | 35.42 | 58 | 40.28 | 144 |
V5 | 17 | 11.97 | 15 | 10.56 | 49 | 34.51 | 61 | 42.96 | 142 |
V6 | 16 | 11.35 | 13 | 9.22 | 43 | 30.50 | 69 | 48.94 | 141 |
V7 | 18 | 12.77 | 9 | 6.38 | 40 | 28.37 | 74 | 52.48 | 141 |
V8 | 17 | 12.06 | 13 | 9.22 | 22 | 15.60 | 89 | 63.12 | 141 |